维普中文期刊产品整合服务
11篇 您的检索式:作者名="Ulrich Lehmann"
    题名 作者 年代 出处 被引量
1DNA methylation,microRNAs,and their crosstalk as potential biomarkers in hepatocellular carcinoma显示文摘Epigenetic alterations have been identified as a major characteristic in human cancers.Advances in the field of epigenetics have contributed significantly in refining our knowledge of molecular mechanisms underlying malignant transformation.DNA methylation and microRNA expression are epigenetic mechanisms that are widely altered in human cancers including hepatocellular carcinoma(HCC),the third leading cause of cancer related mortality worldwide.Both DNA methylation and microRNA expression patterns are regulated in developmental stage specific-,cell type specific-and tissue-specific manner.The aberrations are inferred in the maintenance of cancer stem cells and in clonal cell evolution during carcinogenesis.The availability of genome-wide technologies for DNA methylation and microRNA profiling has revolutionized the field of epigenetics and led to the discovery of a number of epigenetically silenced microRNAs in cancerous cells and primary tissues.Dysregulation of these microRNAs affects several key signalling pathways in hepatocarcinogenesis suggesting that modulation of DNA methylation and/or microRNA expression can serve as new therapeutic targets for HCC.Accumulative evidence shows that aberrant DNA methylation of certain microRNA genes is an event specifically found in HCC which correlates with unfavorable outcomes.Therefore,it can potentially serve as a biomarker for detection as well as for prognosis,monitoring and predicting therapeutic responses in HCC.Sumadi Lukman Anwar Ulrich Lehmann 2014World Journal of Gastroenterology2014,20,24:11
2hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma显示文摘AIM To screen clinically relevant micro RNAs (mi RNAs) silenced by DNA methylation in human hepatocellular carcinoma(HCC).METHODS Knockdown of DNA methyltransferases (DNMTs) using si RNAs and mi RNA profiling in HCC cell lines were performed to identify DNA hypermethylation-mediated mi RNA downregulation. Confirmation using individual quantitative real-time PCR (qR T-PCR) assays was thenperformed followed by DNA methylation quantification at the promoter of the mi RNA genes. Quantification of DNA methylation and mi RNA expression was then performed in primary HCC tumor samples and related with clinicopathological variables.RESULTS mi RNA profiling after DNMT knockdown in HCC cell lines revealed upregulation of mi R-23, mi R-25 and mi R-183. After q RT-PCR confirmation and Cp G island methylation quantification of these miR NAs in cell lines, further analysis in primary HCC specimens showed that hsa-mi R-183 is hypermethylated in 30% of HCC (n = 40). Expression of mature miR-183 showed an inverse correlation with DNA methylation levels. In HCC cells, DNMT knockdown and 5-aza-2'-deoxycytidine treatment reduced methylation and stimulated expression of mi R-183. In HCC patients, hypermethylation at hsami R-183 promoter significantly correlates with poor survival (log-rank test P = 0.03). DNA methylation analysis in healthy liver, benign liver tumors (hepatocellular adenoma and focal nodular hyperplasia) and their corresponding adjacent tissues showed absence of hypermethylation supporting the notion that aberrant methylation at hsa-miR-183 is specific for the malignant transformation of hepatocytes.CONCLUSION Our data indicate that hypermethylation of hsa-miR-183 is a frequent event in HCC and potentially useful as a novel surrogate diagnostic and prognostic marker.Sumadi Lukman Anwar Till Krech Britta Hasemeier Elisa Schipper Nora Schweitzer Arndt Vogel Hans Kreipe Reena Buurman Britta Skawran Ulrich Lehmann 2017World Journal of Gastroenterology2017,23,9:3
3Common and epithelioid variants of hepatic angiomyolipoma exhibit clonal growth and share a distinctive immunophenotype显示文摘Peer Flemming Ulrich Lehmann Thomas Becker Jürgen Klempnauer Hans Kreipe 2000Hepatology2000,,:2
4Limited value of KAI1/CD82 protein expression as a prognosticmarker in human gastric cancer显示文摘Maximilian Knoener Till Krech Florian Puls Ulrich Lehmann Hans Kreipe Matthias Christgen 2012Disease Markers2012,,6:1
5Intratumoral Onyx embolisation in the management of juvenile nasopharyn gem angiofibroma显示文摘LEHMANN M ULRICH S REINEKE U 2010Hno2010,58,8:1
6ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells显示文摘Till Krech Elisa Scheuerer Robert Geffers Hans Kreipe Ulrich Lehmann Matthias Christgen 2011Cancer Letters2011,,2:1
7Plexiform Lesions in Pulmonary Arterial Hypertension显示文摘Danny Jonigk Heiko Golpon Clemens L. Bockmeyer Lavinia Maegel Marius M. Hoeper Jens Gottlieb Nils Nickel Kais Hussein Ulrich Maus Ulrich Lehmann Sabina Janciauskiene Tobias Welte Axel Haverich Johanna Rische Hans Kreipe Florian Laenger 2011The American Journal of Pathology2011,,1:1
8GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study显示文摘Ulrich H. Frey Susanne Moebus Stefan M?hlenkamp Hagen K?lsch Marcus Bauer Nils Lehmann Markus N?then Thomas W. Mühleisen Andreas Stang Raimund Erbel Karl-Heinz J?ckel Jürgen Peters Winfried Siffert 2014Atherosclerosis2014,,2:1
9Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker显示文摘Sumadi Lukman Anwar Cord Albat Till Krech Britta Hasemeier Elisa Schipper Nora Schweitzer Arndt Vogel Hans Kreipe Ulrich Lehmann 2013Int J Cancer2013,,3:1
10Telomerase Deletion Limits Progression of p53-Mutant Hepatocellular Carcinoma With Short Telomeres in Chronic Liver Disease显示文摘André Lechel Henne Holstege Yvonne Begus Andrea Schienke Kenji Kamino Ulrich Lehmann Stefan Kubicka Peter Schirmacher Jos Jonkers K. Lenhard Rudolph 2007Gastroenterology2007,,4:1
11Intravenous free and dipeptide-bound glutamine maintains intestinal microcirculation in experimental endotoxemia显示文摘Christian Lehmann Dragan Pavlovic Juan Zhou Ulrich Wuttke Daniela Saeger Alexander Spassov Orlando Hung Vladimir Cerny Tobias Witter Sara Whynot Ulrich Suchner Birgit Alteheld Peter Stehle Matthias Gründling 2012Nutrition2012,,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费